期刊
ATHEROSCLEROSIS
卷 196, 期 1, 页码 98-105出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.atherosclerosis.2007.02.005
关键词
atherosclerosis pathophysiology; calcification; macrophage; inflammation
资金
- Wellcome Trust Funding Source: Medline
Macrophages may promote a vicious cycle of inflammation and calcification in the vessel wall by ingesting neointimal calcific deposits (predominantly hydroxyapatite) and secreting tumor necrosis factor (TNF)alpha, itself a vascular calcifying agent. Here we have investigated whether particle size affects the proinflammatory potential of hydroxyapatite crystals in vitro and whether the nuclear factor (NF)-kappa B pathway plays a role in the macrophage TNF alpha response. The particle size and nano-topography of nine different crystal preparations was analyzed by X-ray diffraction, Raman spectroscopy, scanning electron microscopy and gas sorbtion analysis. Macrophage TNF alpha secretion was inversely related to hydroxyapatite particle size (P = 0.011, Spearman rank correlation test) and surface pore size (P = 0.014). A necessary role for the NF-kappa B pathway was demonstrated by time-dependent I kappa B alpha degradation and sensitivity to inhibitors of I kappa B alpha degradation. To test whether smaller particles were intrinsically more bioactive, their mitogenic activity on fibroblast proliferation was examined. This showed close correlation between TNF alpha secretion and crystal-induced fibroblast proliferation (P = 0.007). In conclusion, the ability of hydroxyapatite crystals to stimulate macrophage TNF alpha secretion depends on NF-kappa B activation and is inversely related to particle and pore size, with crystals of 1-2 mu m diameter and pore size of 10-50 angstrom the most bioactive. Microscopic calcitic deposits in early stages of atherosclerosis may therefore pose a greater inflammatory risk to the plaque than macroscopically or radiologically visible deposits in more advanced lesions. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据